ArticleBritish journal of haematology2025

The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomas.

Rahul Lakhotia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.